Dishman Carbogen Amcis trades higher on planning to invest $50 million in France to set up new facility
Dishman Carbogen Amcis is currently trading at Rs. 217.15, up by 3.90 points or 1.83% from its previous closing of Rs. 213.25 on the BSE.
The scrip opened at Rs. 219.95 and has touched a high and low of Rs. 219.95 and Rs. 215.40 respectively. So far 24200 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 259.50 on 07-Oct-2021 and a 52 week low of Rs. 102.55 on 25-Mar-2021.
Last one week high and low of the scrip stood at Rs. 239.40 and Rs. 210.20 respectively. The current market cap of the company is Rs. 3410.82 crore.
The promoters holding in the company stood at 59.32%, while Institutions and Non-Institutions held 12.66% and 28.01% respectively.
Dishman Carbogen Amcis (DCAL) is planning to invest $50 million in France to set up a new facility for manufacturing formulated products, mainly in the form of parenterals. The new facility would begin commercial production from January 2023 with two manufacturing lines.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.
